Genomic Testing Quiz

Take this quiz to test your knowledge about genomic testing and other important genomic, genetic and biomarker information.

Quiz takes less than 1 minute to complete.

Lung cancer has the largest number of FDA approved targeted therapies for any cancer including drugs that target alterations in EGFR, ALK, ROS1, RET, MET, NTRK and BRAF
Germline pathogenic variants in BRCA1 and BRCA1 increases the susceptibility to get ovarian and breast cancers
My father died of colorectal cancer when he was 38 years old. I should go to a genetic counselor and evaluate my risk of getting hereditary cancers
Immune checkpoint inhibitors have been approved by the FDA to treat cancers that are microsatellite unstable
Liquid biopsies provide a non-invasive approach of detecting mutations in your tumor

Almost Done!

Please complete the required fields and we will send results to your email.

Full name
Email
Phone

The genomic testing quiz introduces several gene alterations that increases the possibility of developing cancer. Gene mutations associated with cancer can be hereditary/germline (passed on from one of the parents) or somatic (acquired during the patient’s lifetime). Approximately 5-10% of breast cancers and 3-5% of colorectal cancer are hereditary while lung cancer is almost always non-inherited. Patients with germline mutations in BRCA1 and BRCA2 has a 70% lifetime risk of developing breast or ovarian cancer. Conversely, environmental factors such as smoking and asbestos exposure predisposes the patient to develop malignancies such as lung cancer and mesothelioma, respectively.

When a patient receives hereditary genomic testing, a negative test result indicates that the examined family member has not inherited the gene variant that may be present in their family and this individual does not have the inherited risk of developing cancer. It is important to note that the negative result does not mean that there isn’t any threat of cancer, but rather that the risk might be the same as other individuals. On the other hand, the presence of a susceptible gene variant does not imply that the patient will inevitably develop cancer, but rather provides information to mitigate risk.

Who Should Get Genomic Testing?

Doctors will recommend genomic testing if the patient has not responded to frontline treatments such as chemotherapy, radiotherapy or surgery.  Additionally, genomic tests may be considered for patients with a family history of cancer. Genomic testing enables the premise of precision medicine to give the right drug to the right patient at the right time. When the genomic testing results are available, talk with your oncologist or the genetic counsellor about the interpretation of the results and the implications to your family